Rxivist logo

The PRMT7-dependent methylation of shank2 modulates invasion-proliferation switching during breast cancer metastasis

By Yingqi Liu, Junhua Li, Lingxia Liu, Yibo Wang, Lu Peng, Jiayuan Liu, Lingling Li, Lian Zhang, Guannan Wang, Honghuan Li, Dongxu Liu, Baiqu Huang, Jun Lu, Yu Zhang

Posted 07 Aug 2019
bioRxiv DOI: 10.1101/728410

Invasiveness of cancer cells is associated with proliferation inhibition in multiple types of cancers. Here, we identified the pivotal roles of Arginine methyltransferase PRMT7 in promoting invasion and attenuating proliferation of breast cancer cells. PRMT7 exerted its functions through binding to the scaffold protein shank2 to induce the di-methylation of shank2 at R240. Shank2 R240 methylation exposed ANK domain by disrupting its SPN-ANK domain blockade. Moreover, shank2 R240 methylation rendered recruitment of FAK that elicited the FAK auto-phosphorylation, which consequently augmented the shank2-dependent migration and invasion of breast cancer cells. On the other hand, the shank2 R240 methylation impeded proliferation of breast cancer cells by antagonizing the Ras-Raf binding via tethering the mono-ubiquitinated H-Ras. These findings characterize the PRMT7-dependent shank2 methylation as a key player in mediating reciprocal switching between invasion and proliferation, also point to the value of shank2 R240 methylation as a target for tumour metastasis treatment strategies.

Download data

  • Downloaded 298 times
  • Download rankings, all-time:
    • Site-wide: 85,940
    • In cancer biology: 2,568
  • Year to date:
    • Site-wide: 108,373
  • Since beginning of last month:
    • Site-wide: 123,135

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)